Medtronic beats estimates on Q3 and hikes earnings outlook

Medtronic posted better-than-expected sales and profits for the med-tech giant's fiscal third quarter. MarketWatch has an early report on the numbers from Medtronic, which is legally headquartered in Dublin but has its management base in Fridley. For the quarter ended Jan. 25, Medtronic (NYSE: MDT) posted earnings of $1.27 billion, or 94 cents a share, down from $1.59 billion, or $1.17 per share in the same period a year ago. Excluding one-time effects, adjusted earnings came to $1.29 per share,…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news